These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


803 related items for PubMed ID: 16989457

  • 21. Association Between Nonoptimal Blood Pressure and Cochlear Function.
    Baiduc RR, Ramsey M, Sanders A, Vance EA.
    Ear Hear; 2021; 42(2):393-404. PubMed ID: 32826511
    [Abstract] [Full Text] [Related]

  • 22. Two-source interference as the major reason for auditory-threshold estimation error based on DPOAE input-output functions in normal-hearing subjects.
    Dalhoff E, Turcanu D, Vetešník A, Gummer AW.
    Hear Res; 2013 Feb; 296():67-82. PubMed ID: 23268357
    [Abstract] [Full Text] [Related]

  • 23. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Oncology; 2006 Feb; 70(3):177-84. PubMed ID: 16757924
    [Abstract] [Full Text] [Related]

  • 24. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM.
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [Abstract] [Full Text] [Related]

  • 25. Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes.
    McMillan GP, Konrad-Martin D, Dille MF.
    Int J Audiol; 2012 Sep; 51(9):689-96. PubMed ID: 22676700
    [Abstract] [Full Text] [Related]

  • 26. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A.
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [Abstract] [Full Text] [Related]

  • 27. [Objective audiometry with DPOAEs : New findings for generation mechanisms and clinical applications. German version].
    Zelle D, Dalhoff E, Gummer AW.
    HNO; 2016 Nov; 64(11):822-830. PubMed ID: 27761597
    [Abstract] [Full Text] [Related]

  • 28. Distortion product otoacoustic emissions and sensorineural hearing loss.
    Moulin A, Bera JC, Collet L.
    Audiology; 1994 Nov; 33(6):305-26. PubMed ID: 7741665
    [Abstract] [Full Text] [Related]

  • 29. Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions.
    Md Daud MK, Mohamadl H, Haron A, Rahman NA.
    B-ENT; 2014 Nov; 10(1):53-8. PubMed ID: 24765829
    [Abstract] [Full Text] [Related]

  • 30. [DPOAE in tinnitus patients with cochlear hearing loss considering hyperacusis and misophonia].
    Sztuka A, Pośpiech L, Gawron W, Dudek K.
    Otolaryngol Pol; 2006 Nov; 60(5):765-72. PubMed ID: 17263252
    [Abstract] [Full Text] [Related]

  • 31. Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions.
    Parazzini M, Hall AJ, Lutman ME, Kapadia S.
    Hear Res; 2005 Jul; 205(1-2):44-52. PubMed ID: 15953514
    [Abstract] [Full Text] [Related]

  • 32. Long-Term Variability of Distortion-Product Otoacoustic Emissions in Infants and Children and Its Relation to Pediatric Ototoxicity Monitoring.
    Konrad-Martin D, Knight K, McMillan GP, Dreisbach LE, Nelson E, Dille M.
    Ear Hear; 2020 Jul; 41(2):239-253. PubMed ID: 29280917
    [Abstract] [Full Text] [Related]

  • 33. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA, Baranowski LG.
    Ear Hear; 2012 Jul; 33(2):239-49. PubMed ID: 21918451
    [Abstract] [Full Text] [Related]

  • 34. [Evaluation of cochlear function in children with chronic renal failure].
    Hajduk A, Lisowska G, Namysłowski G, Szprynger K, Szczepańska M, Widziszowska A.
    Pol Merkur Lekarski; 2005 Sep; 19(111):304-6. PubMed ID: 16358851
    [Abstract] [Full Text] [Related]

  • 35. Fine alterations of distortion-product otoacoustic emissions after moderate acoustic overexposure in guinea pigs.
    Kossowski M, Mom T, Guitton M, Poncet JL, Bonfils P, Avan P.
    Audiology; 2001 Sep; 40(3):113-22. PubMed ID: 11465293
    [Abstract] [Full Text] [Related]

  • 36. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K.
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [Abstract] [Full Text] [Related]

  • 37. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T, Kandzia F, Oswald JA, Janssen T.
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [Abstract] [Full Text] [Related]

  • 38. [Hearing evaluation in chronic renal failure children].
    Hajduk A, Lisowska G, Namysłowski G, Szprynger K, Szczepańska M, Widziszowska A.
    Otolaryngol Pol; 2006 Feb; 60(1):61-6. PubMed ID: 16821544
    [Abstract] [Full Text] [Related]

  • 39. Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma.
    Bhagat SP, Bass JK, White ST, Qaddoumi I, Wilson MW, Wu J, Rodriguez-Galindo C.
    Int J Pediatr Otorhinolaryngol; 2010 Oct; 74(10):1156-63. PubMed ID: 20667604
    [Abstract] [Full Text] [Related]

  • 40. ABR and DPOAE detection of cochlear damage by gentamicin.
    Shi Y, Martin WH.
    J Basic Clin Physiol Pharmacol; 1997 Oct; 8(3):141-55. PubMed ID: 9429983
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 41.